Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that India Ratings and Research has assigned Long-term issuer rating of ‘IND AA+’ Rating for the company. The instrument-wise ratings are enclosed. The Company has received the rating letter from India Ratings and Research on December 26, 2022.
The above information is a part of company’s filings submitted to BSE.